What is the success rate of using intrauterine fluid as an American IVF? American in vitro fertilization (IVF) has benefited from advanced IVF technology, high-end medical equipment, and the full support and support of profound reproductive medicine experts, resulting in a high success rate. We aim to create a safe and efficient IVF cycle for our customers and achieve their dreams of reproduction. Let's take a look at the high success rate of using intrauterine fluid as an IVF in the United States.

What is the success rate of using intrauterine fluid as an IVF in the United States

Due to the different physical conditions and degree of hydronephrosis in the uterine cavity of each woman, their success rate may also vary, depending on the actual situation. For example, experts from HRC Reproductive Hospital in the United States will customize a suitable IVF plan based on the customer's actual physical condition. By scientifically applying advanced reproductive technology to assist in pregnancy, coupled with strict control and standardized operation throughout the process, the IVF success rate can be significantly improved, Realize your dream of good pregnancy as soon as possible.

The impact of intrauterine hydronephrosis on fertility

Hysterosis can be divided into two types: physiological and pathological. Generally speaking, physiological hydronephrosis often occurs after ovulation or early pregnancy, and it does not require treatment and can resolve on its own; However, pathological hydronephrosis is generally caused by inflammation. If left untreated, the area of hydronephrosis will continue to expand, leading to recurrent attacks and affecting physical health, directly affecting the occurrence of adverse conditions such as female pregnancy or ectopic pregnancy.

Inflammation induced hydronephrosis, if not diagnosed and treated in a timely manner, can easily cause pelvic adhesions, blocked fallopian tubes, and lead to infertility. In addition, the microorganisms and toxic substances contained in the hydronephrosis can also harm the embryo, affecting its implantation and development. When the hydronephrosis reaches a certain level, it can also inhibit the growth and development of the embryo, leading to miscarriage. Hydronephrosis in the uterine cavity can also reduce the receptivity of the uterus, Therefore, if women with uterine hydronephrosis go to the United States for IVF treatment, experts will first seek treatment and wait for the hydronephrosis to dissipate before entering the IVF cycle, which will increase the success rate.

The Solution to Hysterosis in American IVF

1. Diagnosis and treatment of hydronephrosis in the uterine cavity

Targeted diagnosis and treatment of intrauterine hydrops should be carried out based on the physical condition of women. For women with mild hydrops or adhesions, intravenous supplementation of nutrients and water can be used to correct electrolyte disorders. In addition, hysteroscopy can be used to clear the uterus and adhesions. After the inflammation is eliminated, combined with the hormone level of women, medication can be used to assist in intrauterine treatment, promoting the recovery of uterine fish to the desired thickness and making sufficient preparations for transplantation.

2. Scientific promotion of ovulation and genetic testing

Develop suitable ovulation promotion plans for women who have managed their bodies well, and standardize the use of drugs to promote ovulation to obtain high-quality and mature eggs. Single sperm injection ICT technology can be used to combine sperm with the egg and cultivate high-quality blastocysts in the fertilized egg until the fifth day. Then, the third generation in vitro fertilization technology can be used to perform full gene testing on the blastocyst chromosomes, screen and diagnose chromosomal abnormalities or carrying defective genes in the embryo.

3. Embryo transfer, medication for fetal protection

Before IVF transplantation, corresponding drugs are used to regulate the uterine environment. When the thickness of the uterine cavity reaches 8-12mm, there is sufficient blood supply, cell division is good, and there are no other uterine diseases, healthy blastocyst transplantation is chosen. After transplantation, appropriate doses of progesterone or HCG are given according to the situation to improve uterine receptivity, so that the embryo can implant more smoothly, while suppressing the occurrence of immune reactions and preventing miscarriage.